You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CYANOCOBALAMIN Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Cyanocobalamin patents expire, and what generic alternatives are available?

Cyanocobalamin is a drug marketed by Abraxis Pharm, Am Regent, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Luitpold, Lyphomed, Mankind Pharma, Mylan Institutional, Mylan Labs Ltd, Sagent Pharms Inc, Sandoz, Sanofi Aventis Us, Sola Pharms, Solopak, Somerset Theraps Llc, Vitruvias Therap, Warner Chilcott, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Xiromed, Zydus Pharms, Lupin, Padagis Israel, and West Ward. and is included in thirty NDAs.

The generic ingredient in CYANOCOBALAMIN is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cyanocobalamin

A generic version of CYANOCOBALAMIN was approved as cyanocobalamin by PADAGIS ISRAEL on September 9^th, 2020.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CYANOCOBALAMIN?
What are the global sales for CYANOCOBALAMIN?
What is Average Wholesale Price for CYANOCOBALAMIN?

Summary for CYANOCOBALAMIN

US Patents:	0
Applicants:	29
NDAs:	30
Finished Product Suppliers / Packagers:	22
Raw Ingredient (Bulk) Api Vendors:	79
Clinical Trials:	39
Patent Applications:	1,498
Drug Prices:	Drug price information for CYANOCOBALAMIN
Drug Sales Revenues:	Drug sales revenues for CYANOCOBALAMIN
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CYANOCOBALAMIN
DailyMed Link:	CYANOCOBALAMIN at DailyMed

Drug patent expirations by year for CYANOCOBALAMIN

Drug Prices for CYANOCOBALAMIN

Recent Clinical Trials for CYANOCOBALAMIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Fundação Educacional Serra dos Órgãos	Phase 4
University of Kansas Medical Center	Phase 2
Tanta University	Phase 3

See all CYANOCOBALAMIN clinical trials

Pharmacology for CYANOCOBALAMIN

Drug Class	Vitamin B12

Anatomical Therapeutic Chemical (ATC) Classes for CYANOCOBALAMIN

B03BA	Vitamin B12 (cyanocobalamin and analogues)
B03B	VITAMIN B12 AND FOLIC ACID
B03	ANTIANEMIC PREPARATIONS
B	Blood and blood forming organs

Paragraph IV (Patent) Challenges for CYANOCOBALAMIN

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
NASCOBAL	Nasal Spray	cyanocobalamin	500 mcg/spray	021642	1	2017-04-28

US Patents and Regulatory Information for CYANOCOBALAMIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Ayerst	CYANOCOBALAMIN	cyanocobalamin	INJECTABLE;INJECTION	080554-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	CYANOCOBALAMIN	cyanocobalamin	INJECTABLE;INJECTION	083120-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Xiromed	CYANOCOBALAMIN	cyanocobalamin	INJECTABLE;INJECTION	215046-001	Aug 20, 2021		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.